Human plasma, a protein-rich liquid making up 55% of our blood, is crucial for developing therapies for various conditions, including rare inherited disorders and immunodeficiencies.
Despite its importance, Europe's plasma supply chain is vulnerable, relying on the generosity of human donors. Over 12 million Europeans donate plasma annually, governed by EU and international safety standards, such as the International Quality Plasma Program (IQPP) and the Plasma Protein Therapeutics Association (PPTA).
Plasma is singularly human, existing only thanks to the generosity of real people.
Author's summary: Europe relies heavily on human plasma donations.